Form D — Cime Therapeutics Inc.
0002062575-25-000001 · filed 2025-03-21
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,500,000
- Total sold
- $2,100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cime Therapeutics Inc.
- CIK
- 2062575
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 110 16TH STREET
DENVER, CO 80202 - Phone
- 760-703-5380
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
James Thomas Brewster II · Executive OfficerDenver, CO Find on LinkedIn ↗
-
Chris Erickson · DirectorDenver, CO Find on LinkedIn ↗
View original on SEC EDGAR.